| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,861 |
22,947 |
$2.06M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,721 |
5,205 |
$704K |
| 99215 |
Prolong outpt/office vis |
6,675 |
6,028 |
$672K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,236 |
2,100 |
$351K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,829 |
4,128 |
$250K |
| Q3014 |
Telehealth originating site facility fee |
4,924 |
4,554 |
$104K |
| 95251 |
|
4,034 |
3,525 |
$102K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,164 |
1,007 |
$78K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,729 |
7,755 |
$45K |
| 95250 |
|
472 |
382 |
$39K |
| 73630 |
|
846 |
457 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
290 |
206 |
$8K |
| 93922 |
|
111 |
106 |
$6K |
| 95923 |
|
67 |
59 |
$6K |
| 93923 |
|
75 |
67 |
$6K |
| 11730 |
|
84 |
73 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
161 |
91 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
131 |
126 |
$2K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
15 |
12 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
12 |
$1K |
| 93970 |
|
17 |
12 |
$1K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
15 |
12 |
$1K |
| 84439 |
|
131 |
126 |
$1K |
| 92060 |
|
15 |
15 |
$578.56 |
| 93015 |
|
15 |
12 |
$525.17 |
| 76536 |
|
18 |
14 |
$381.32 |
| 20550 |
|
15 |
13 |
$221.28 |
| 11721 |
|
308 |
303 |
$213.40 |
| 11056 |
|
199 |
194 |
$182.38 |
| 99091 |
|
983 |
832 |
$119.40 |
| 82948 |
|
113 |
101 |
$94.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
13 |
$7.20 |
| 36415 |
Collection of venous blood by venipuncture |
145 |
140 |
$3.98 |
| 99072 |
|
1,510 |
1,360 |
$3.09 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
152 |
143 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
569 |
540 |
$0.00 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
33 |
27 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
13 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13 |
12 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
549 |
526 |
$0.00 |
| 97802 |
|
36 |
22 |
$0.00 |
| 99457 |
|
18 |
17 |
$0.00 |